STOCK TITAN

22nd Century Group to Present at the LD Micro 500 Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

22nd Century Group (NYSE American: XXII) will present at the LD Micro 500 Virtual Conference on September 3, 2020, at 4:20 p.m. ET. The executive team will be available for one-on-one meetings with investors on September 3 and 4. A live webcast will be accessible on the company’s Investors webpage, with archived replays available post-event. The company specializes in plant-based biotechnology and has innovative products, such as reduced nicotine tobacco. Their expertise extends to developing unique varieties in hemp and cannabis, holding over 200 patents.

Positive
  • None.
Negative
  • None.

WILLIAMSVILLE, N.Y., Aug. 27, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based life science company driven by next generation plant biotechnology, today announced that the Company’s executive management team will present at the LD Micro 500 Virtual Conference on Thursday, September 3, 2020 at 4:20 p.m. ET and will be available for one-on-one meetings with investors throughout the day on September 3 and 4, 2020.

The live webcast and presentation will be accessible in the Investors section of 22nd Century’s website under Events. An archived replay of the webcast will be available shortly after the live event.

Please visit https://ld500.ldmicro.com/ to register for the conference.

About 22nd Century Group, Inc.
22nd Century Group, Inc. (NYSE American: XXII) is a leading, plant-based, life science company that develops and provides unique, commercial solutions to the life science, consumer products, and pharmaceutical markets. Using plant genetic engineering and modern plant breeding techniques to create new, proprietary plants and intellectual property, 22nd Century seeks to enhance and broaden the consumer experience by providing natural, plant-derived ingredients to product formulators and manufacturers. In the tobacco plant, 22nd Century is able to modulate the levels of nicotine that naturally occur in the plant. With this technology, 22nd Century is poised to disrupt the global tobacco market with its proprietary reduced nicotine content tobacco cigarettes containing 95% less nicotine than conventional tobacco and cigarettes. 22nd Century is applying its plant genetics expertise to the hemp/cannabis plant as well to develop new and proprietary varieties of hemp/cannabis with unique cannabinoid and terpene profiles and desirable agronomic traits. 22nd Century also owns or controls the rights to commercialize over 200 issued and pending patents related to the tobacco and hemp/cannabis plants.

Learn more at xxiicentury.com, on Twitter @_xxiicentury and on LinkedIn.

About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone. For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:
Mei Kuo
22nd Century Group
(716) 300-1221
mkuo@xxiicentury.com

John Mills
ICR
(646) 277-1254
john.mills@icrinc.com

Deirdre Thomson
ICR
(646) 277-1283
deirdre.thomson@icrinc.com


FAQ

When will 22nd Century Group present at the LD Micro 500 Virtual Conference?

22nd Century Group will present at the LD Micro 500 Virtual Conference on September 3, 2020, at 4:20 p.m. ET.

How can I access the webcast for 22nd Century Group's conference presentation?

You can access the live webcast of 22nd Century Group's presentation on their Investors webpage.

What are the dates for one-on-one meetings with investors for XXII?

One-on-one meetings with investors for 22nd Century Group will take place on September 3 and 4, 2020.

What is 22nd Century Group's focus in plant biotechnology?

22nd Century Group focuses on creating unique, plant-derived products, including reduced nicotine tobacco and specialized cannabis varieties.

How many patents does 22nd Century Group hold related to tobacco and cannabis?

22nd Century Group owns or controls over 200 issued and pending patents related to tobacco and cannabis.

22nd Century Group Inc.

NASDAQ:XXII

XXII Rankings

XXII Latest News

XXII Stock Data

2.84M
264.01k
23.05%
9.8%
0.53%
Tobacco
Cigarettes
Link
United States of America
WILLIAMSVILLE